Topiramate’s effects on normal and fatty liver

References

• Agarwal, N. B., Agarwal, N. K., Mediratta, P. K., & Sharma, K. K. (2011). Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure, 20(3), 257–262.
   PubMed Web of Science ®Google Scholar
• Asconapé, J. J. (2014). Use of antiepileptic drugs in hepatic and renal disease. Handbook of Clinical Neurology, 119, 417–432.
   PubMedGoogle Scholar
• Bahar, A., Ozmen Senturk, B., Buyukdemir, S., Kutluturk, G., Mutlu, Z. N., Baki, S., Kulaksiz, B., Altinkaynak, M., & Saka, B., Selimiye Vocational and Technical Anatolian High School, Ministry of Education, Istanbul, Turkey. (2020). The prevalence of obesity in adolescent age group and its relationship with dietary habbits, family history, anthropometric measurements and muscle analysis. Clinical Science of Nutrition, 2(1), 21–29.
   Google Scholar
• Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism: Clinical and Experimental, 65(8), 1038–1048.
   PubMed Web of Science ®Google Scholar
• Cardile, V., Pavone, A., Renis, M., Maci, T., & Perciavalle, V. (2001). Effects of gabapentin and topiramate in primary rat astrocyte cultures. Neuroreport, 12(8), 1705–1708.
   PubMed Web of Science ®Google Scholar
• Chen, G., Chen, Y., Xie, Y., Huang, R., Chen, T., Shi, P., Zhang, Z., Hou, Y., Xing, W., & Wei, L. (2020). Topiramate for hypoxic ischemic encephalopathy: A systematic review protocol. Medicine, 99(17), e18704
   PubMed Web of Science ®Google Scholar
• Cunningham, R. P., Moore, M. P., Moore, A. N., Healy, J. C., Roberts, M. D., Rector, R. S., & Martin, J. S. (2018). Curcumin supplementation mitigates NASH development and progression in female Wistar rats. Physiological Reports, 6(14), e13789.
   PubMed Web of Science ®Google Scholar
• Czepiel, K. S., Perez, N. P., Campoverde Reyes, K. J., Sabharwal, S., & Stanford, F. C. (2020). Pharmacotherapy for the treatment of overweight and obesity in children, adolescents, and young adults in a large health system in the US. Frontiers in Endocrinology, 11, 290.
   PubMed Web of Science ®Google Scholar
• Dhillon, S. (2022). Phentermine/Topiramate: Pediatric first approval. Paediatric Drugs, 24(6), 715–720.
   PubMed Web of Science ®Google Scholar
• Di Fiore, A., Monti, D. M., Scaloni, A., De Simone, G., & Monti, S. M. (2018). Protective role of carbonic anhydrases III and VII in cellular defense mechanisms upon redox unbalance. Oxidative Medicine and Cellular Longevity, 2018, 2018306–2018309.
   PubMed Web of Science ®Google Scholar
• Dodgson, S. J. (1991). Why are there carbonic anhydrases in the liver? Biochimie et biologie cellulaire[Biochemistry and Cell Biology], 69(12), 761–763.
   PubMed Web of Science ®Google Scholar
• Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000). Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia, 41(S1), 35–39.
   PubMedGoogle Scholar
• El Makawy, A. I., Mabrouk, D. M., Ibrahim, F. M., & Ahmed, K. A. (2022). Genotoxic, biochemical and histopathological studies to assessment the topiramate hepatorenal toxicity in mice. Drug and Chemical Toxicology, 45(1), 103–112.
   PubMedGoogle Scholar
• Eyer, P., Worek, F., Kiderlen, D., Sinko, G., Stuglin, A., Simeon-Rudolf, V., & Reiner, E. (2003). Molar absorption coefficients for the reduced Ellman reagent: Reassessment. Analytical Biochemistry, 312(2), 224–227.
   PubMed Web of Science ®Google Scholar
• Fuchs, W., Steger, F., Reich, J., Ribitsch, D., Rittmann, S. K.-M R., & Bochmann, G. (2021). A simple and straightforward method for activity measurement of carbonic anhydrases. Catalysts, 11(7), 819
   Web of Science ®Google Scholar
• Garris, S. S., & Oles, K. S. (2005). Impact of topiramate on serum bicarbonate concentrations in adults. The Annals of Pharmacotherapy, 39(3), 424–426.
   PubMed Web of Science ®Google Scholar
• Golabi, P., Bush, H., & Younossi, Z. M. (2017). Treatment strategies for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clinics in Liver Disease, 21(4), 739–753.
   PubMed Web of Science ®Google Scholar
• Gupta, S., Gao, J. J., Emmett, M., & Fenves, A. Z. (2017). Topiramate and metabolic acidosis: An evolving story. Hospital Practice, 45(5), 192–195.
   PubMedGoogle Scholar
• Huang, J., et al. (2007). An experimental study on hepatotoxicity of topiramate in young rats. Zhongguo dang dai er ke za zhi [Chinese Journal of Contemporary Pediatrics], 9(1), 54–58.
   PubMedGoogle Scholar
• Jafari, A., Ghasemnejad-Berenji, H., Nemati, M., & Ghasemnejad-Berenji, M. (2021). Topiramate: A novel protective agent against ischemia reperfusion-induced oxidative injury after testicular torsion/detorsion. The American Journal of Emergency Medicine, 44, 257–261.
   PubMed Web of Science ®Google Scholar
• Kılınç, S., & Güney, S. (2019). Effects of hypoxic preconditioning on oxidant-antioxidant systems in rat lung. Turkiye Klinikleri Journal of Medical Sciences, 39(2), 194–201.
   Google Scholar
• Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y.-C., Torbenson, M. S., Unalp-Arida, A., Yeh, M., McCullough, A. J., & Sanyal, A. J, Nonalcoholic Steatohepatitis Clinical Research Network. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 41(6), 1313–1321.
   PubMed Web of Science ®Google Scholar
• Kucera, O., & Cervinkova, Z. (2014). Experimental models of non-alcoholic fatty liver disease in rats. World Journal of Gastroenterology, 20(26), 8364–8376.
   PubMed Web of Science ®Google Scholar
• Liang, Y., She, P., Wang, X., & Demarest, K. (2006). The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment. Metabolism: Clinical and Experimental, 55(10), 1411–1419.
   PubMed Web of Science ®Google Scholar
• Longin, E., Teich, M., Koelfen, W., & König, S. (2002). Topiramate enhances the risk of valproate-associated side effects in three children. Epilepsia, 43(4), 451–454.
   PubMed Web of Science ®Google Scholar
• Machado, M., & Cortez-Pinto, H. (2006). Non-alcoholic steatohepatitis and metabolic syndrome. Current Opinion in Clinical Nutrition and Metabolic Care, 9(5), 637–642.
   PubMed Web of Science ®Google Scholar
• Mihara, M., & Uchiyama, M. (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry, 86(1), 271–278.
   PubMed Web of Science ®Google Scholar
• Motaghinejad, M., & Motevalian, M. (2016). Involvement of AMPA/kainate and GABAA receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus. European Journal of Pharmacology, 784, 181–191.
   PubMed Web of Science ®Google Scholar
• Motaghinejad, M., Motevalian, M., Babalouei, F., Abdollahi, M., Heidari, M., & Madjd, Z. (2017). Possible involvement of CREB/BDNF signaling pathway in neuroprotective effects of topiramate against methylphenidate induced apoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidences. Brain Research Bulletin, 132, 82–98.
   PubMed Web of Science ®Google Scholar
• Motaghinejad, M., Motevalian, M., Falak, R., Heidari, M., Sharzad, M., & Kalantari, E. (2016). Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: The possible role of CREB/BDNF signaling pathway. Journal of Neural Transmission, 123(12), 1463–1477.
   PubMed Web of Science ®Google Scholar
• Motaghinejad, M., Motevalian, M., & Shabab, B. (2016). Neuroprotective effects of various doses of topiramate against methylphenidate induced oxidative stress and inflammation in rat isolated hippocampus. Clinical and Experimental Pharmacology & Physiology, 43(3), 360–371.
   PubMed Web of Science ®Google Scholar
• Muriach, M., López-Pedrajas, R., Barcia, J. M., Sanchez-Villarejo, M. V., Almansa, I., & Romero, F. J. (2010). Cocaine causes memory and learning impairments in rats: İnvolvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. Journal of Neurochemistry, 114(3), 675–684.
   PubMed Web of Science ®Google Scholar
• Niu, T., Li, J., Wang, J., Ma, J. Z., & Li, M. D. (2017). Identification of novel signal transduction, ımmune function, and oxidative stress genes and pathways by topiramate for treatment of methamphetamine dependence based on secondary outcomes. Frontiers in Psychiatry, 8, 271.
   PubMed Web of Science ®Google Scholar
• Pan, C. S., & Stanley, T. L. (2020). Effect of weight loss medications on hepatic steatosis and steatohepatitis: A systematic review. Frontiers in Endocrinology, 11, 70.
   PubMed Web of Science ®Google Scholar
• Polyzos, S. A., Goulis, D. G., Giouleme, O., Germanidis, G. S., & Goulas, A. (2022). Anti-obesity medications for the management of nonalcoholic fatty liver disease. Current Obesity Reports, 11(3), 166–179.
   PubMed Web of Science ®Google Scholar
• Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019). Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism: Clinical and Experimental, 92, 82–97.
   PubMed Web of Science ®Google Scholar
• Price, T. O., Eranki, V., Banks, W. A., Ercal, N., & Shah, G. N. (2012). Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology, 153(1), 362–372.
   PubMed Web of Science ®Google Scholar
• Price, T. O., et al. (2015). Protective effect of topiramate on hyperglycemia-ınduced cerebral oxidative stress, pericyte loss and learning behavior in diabetic mice. International Library of Diabetes & Metabolism, 1(1), 6–12.
   PubMedGoogle Scholar
• Salek, T., Andel, I., & Kurfurstova, I. (2017). Topiramate induced metabolic acidosis and kidney stones – a case study. Biochemia Medica, 27(2), 404–410.
   Web of Science ®Google Scholar
• Sarangi, S. C., Kakkar, A. K., Kumar, R., & Gupta, Y. K. (2016). Effect of lamotrigine, levetiracetam & topiramate on neurobehavioural parameters & oxidative stress in comparison with valproate in rats. Indian Journal of Medical Research, 144(1), 104–111.
   Google Scholar
• Savari, F., Mard, S. A., Badavi, M., Rezaie, A., & Gharib-Naseri, M. K. (2019). A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterology, 19(1), 125.
   PubMedGoogle Scholar
• Schreuder, T. C. M. A., Verwer, B. J., van Nieuwkerk, C. M. J., & Mulder, C. J. J. (2008). Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World Journal of Gastroenterology, 14(16), 2474–2486.
   PubMed Web of Science ®Google Scholar
• Seen, T. K., Sayed, M., Bilal, M., Reyes, J. V., Bhandari, P., Lourdusamy, V., Al-Khazraji, A., Syed, U., Sattar, Y., & Bansal, R. (2021). Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology, 27(23), 3238–3248.
   PubMed Web of Science ®Google Scholar
• Shank, R. P., & Maryanoff, B. E. (2008). Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. CNS Neuroscience & Therapeutics, 14(2), 120–142.
   PubMed Web of Science ®Google Scholar
• Sironi, C., Bodega, F., Zocchi, L., & Porta, C. (2019). Effects of creatine treatment on jejunal phenotypes in a rat model of acidosis. Antioxidants, 8(7), 25.
   Web of Science ®Google Scholar
• Takeoka, M., Holmes, G. L., Thiele, E., Bourgeois, B. F., Helmers, S. L., Duffy, F. H., & Riviello, J. J. (2001). Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia, 42(3), 387–392.
   PubMed Web of Science ®Google Scholar
• Tsankof, A., Neokosmidis, G., Koureta, E., Veneti, S., Cholongitas, E., & Tziomalos, K. (2022). Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease? Frontiers in Endocrinology, 13, 984041
   PubMed Web of Science ®Google Scholar
• Tsien, M. Z., Cordova, J., Qadir, A., Zhao, L., Hart, J., & Azzam, R. (2016). Topiramate-ınduced acute liver failure in a pediatric patient: A case report and review of literature. Journal of Pediatric Gastroenterology and Nutrition, 63(3), e37-8–e38.
   PubMedGoogle Scholar
• Vidaurre, J., Gedela, S., & Yarosz, S. (2017). Antiepileptic drugs and liver disease. Pediatric Neurology, 77, 23–36.
   PubMed Web of Science ®Google Scholar
• Wilbur, K. M., & Anderson, N. G. (1948). Electrometric and colorimetric determination of carbonic anhydrase. The Journal of Biological Chemistry, 176(1), 147–154.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2021). Obesity and overweight. Retrieved 25 August from https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweigh.
   Google Scholar